October 5th, 2018, 333 Cedar St in the Harkness Auditorium
The Innovation and Diversity Summit: Patient-Centered Approaches to Care and Research, a collaboration of Yale School of Medicine and our partners at the FDA Office of Minority Health and the YCCI Cultural Ambassadors for Clinical Research, will focus on raising awareness about the need for minorities and subpopulation participation in clinical trials; patient-centered approaches to care and research; and the role of technology in both areas. It is our hope that this event be the first in a series of summits to focus on these issues. Our goal is to bring stakeholders from the governmental agencies, industry, academia, and community to provoke discussion about innovation and clinical trial diversity and raise awareness.
Distinguished speakers include:
- RADM Denise Hinton, chief scientist, FDA
- Captain Richardae Araojo, associate commissioner for minority health, FDA
- Quincy J. Byrdsong, executive director for research administration, WellStar Research Institute
- Linda Coleman, JD, director, Human Research Protection Program
- Eric J. Velazquez, MD, Robert R. Berliner Professor of Medicine (Cardiology); chief, cardiovascular medicine, Yale School of Medicine; physician-in-chief of the Heart and Vascular Center for Yale New Haven Health
- Allen Hsiao, MD, chief medical information officer, Yale School of Medicine and Yale New Haven Health
- Tesheia Johnson, MBA, MHS, deputy director and chief operating officer, Yale Center for Clinical Investigation; associate director for clinical research, Yale School of Medicine
- Members of the Henrietta Lacks family